Aerska
Dublin · Founded 2025
About Aerska
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain disorders.
Company Facts
- Founded: 2025
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $60.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2026)
- Website: https://www.aerska.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Market Research
Social Profiles
Canonical: https://fsome.com/organization/aerska-24674 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.